<DOC>
	<DOCNO>NCT01094262</DOCNO>
	<brief_summary>The purpose study evaluate pain relief , safety , tolerability new treatment ( JNJ-42160443 ) moderate severe pain osteoarthritis knee comparison standard pain treatment placebo .</brief_summary>
	<brief_title>A Safety Tolerability Study JNJ-42160443 Patients With Moderate Severe , Chronic Knee Pain From Osteoarthritis</brief_title>
	<detailed_description>This double-blind ( neither physician patient know name assign drug ) study evaluate pain relief , safety , tolerability new treatment ( JNJ-42160443 ) moderate severe pain osteoarthritis knee comparison standard pain treatment placebo . The study last 42 week . Patients receive treatment 16 week . Patients qualify study base level pain well factor receive one 4 possible treatment determine chance . Before enter study , patient must stop use present pain medication . During study , patient answer question pain , side effect , test perform monitor physical condition . The main purpose study compare pain relief JNJ-42160443 standard pain treatment placebo . After treatment period , patient return take pain medication use start study , physical condition continue monitor . JNJ 42160443 10 mg/mL provide use study . Patients receive 1 4 treatment 16 week ( wks ) : low dosage JNJ 42160443 subcutaneous ( skin ) ( SC ) injection every 4 wks + Placebo ( P ) capsule orally ( mouth ) ( PO ) 2x/day , high dosage JNJ 42160443 SC injection every 4 wks + P capsule PO 2x/day , standard pain medication capsule PO 2x/day + P SC injection every 4 wks , P capsule PO 2x/day + P SC injection every 4 wks .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Clinical diagnosis osteoarthritis knee Have moderate severe pain base trial questionnaire Must stable dose pain medication 4 week enter trial Medically stable condition History joint replacement surgery affect joint plan surgery involve affect joint trial Diabetes mellitus Uncontrolled cardiovascular disease hypertension Previous treatment another investigational NGF inhibitor therapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Osteoarthritis pain knee</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Osteoarthritis , Knee</keyword>
	<keyword>Pain</keyword>
	<keyword>Arthralgia</keyword>
	<keyword>Joint Pain</keyword>
	<keyword>JNJ-42160443</keyword>
</DOC>